G.S.Pharmaceutical Distributors Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 18-07-2024
- Paid Up Capital ₹ 3.60 Cr
as on 18-07-2024
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 18.00 Cr
as on 18-07-2024
- Revenue 13.22%
(FY 2023)
- Profit -28.52%
(FY 2023)
- Ebitda 63.13%
(FY 2023)
- Net Worth -39.10%
(FY 2023)
- Total Assets 17.84%
(FY 2023)
About G.S.Pharmaceutical Distributors
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.60 Cr.
The company currently has active open charges totaling ₹18.00 Cr.
Gaurav Kumar, Shashwat Nigam, and Dipesh Gala serve as directors at the Company.
- CIN/LLPIN
U74999MH2017PTC300189
- Company No.
300189
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Sep 2017
- Date of AGM
05 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at G.S.Pharmaceutical Distributors?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurav Kumar  | Additional Director | 12-Aug-2023 | Current |
| Shashwat Nigam | Additional Director | 14-Aug-2023 | Current |
| Dipesh Gala | Whole-Time Director | 27-Sep-2017 | Current |
Financial Performance and Corporate Structure Insights of G.S.Pharmaceutical Distributors.
G.S.Pharmaceutical Distributors Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.22% increase. The company also saw a substantial fall in profitability, with a 28.52% decrease in profit. The company's net worth observed a substantial decline by a decrease of 39.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of G.S.Pharmaceutical Distributors?
In 2023, G.S.Pharmaceutical Distributors had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Svs Lifesciences Private LimitedActive 2 years 7 monthsGaurav Kumar and Shashwat Nigam are mutual person
- Barros Enterprises Private LimitedActive 5 years 3 months
Gaurav Kumar and Shashwat Nigam are mutual person
- Galaxystar Pharma Distributors Private LimitedActive 6 years 2 months
Gaurav Kumar is a mutual person
- Sundarlal Pharma Distributors Private LimitedActive 6 years 2 months
Gaurav Kumar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Jul 2022 | ₹4.00 Cr | Open |
Others Creation Date: 26 Jun 2019 | ₹14.00 Cr | Open |
How Many Employees Work at G.S.Pharmaceutical Distributors?
G.S.Pharmaceutical Distributors has a workforce of 47 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of G.S.Pharmaceutical Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped G.S.Pharmaceutical Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
